NewslettersMammary Cell NewspH-Triggered Delivery of Pirarubicin-Gemcitabine Duo Using Polymeric Nanoparticles for Synergistic Breast Cancer TherapyBy Jamie Kang - July 3, 2025067Researchers investigated the development of pirarubicin and gemcitabine co-loaded polymeric nanoparticles for synergistic activity against breast cancer cells.[Nanoscale Horizons]AbstractGraphical Abstract